Cargando…
Prucalopride reduces the number of reflux episodes and improves subjective symptoms in gastroesophageal reflux disease: a case series
INTRODUCTION: Treatment of persistence to proton pump inhibitors or non-acid reflux episodes in patients with gastroesophageal reflux disease is challenging. Prucalopride, a selective high affinity serotonin (5-HT(4)) receptor agonist, might offer a possible new therapeutic alterative. CASE PRESENTA...
Autores principales: | Nennstiel, Simon, Bajbouj, Monther, Schmid, Roland M, Becker, Valentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923556/ https://www.ncbi.nlm.nih.gov/pubmed/24502186 http://dx.doi.org/10.1186/1752-1947-8-34 |
Ejemplares similares
-
Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children
por: Malaty, Hoda M, et al.
Publicado: (2009) -
Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease
por: Ye, Bi Xing, et al.
Publicado: (2017) -
Impedance-detected Symptom Association and Number of Reflux Episodes as Pre-treatment Parameters That Predict Outcomes of Gastroesophageal Reflux Disease Patients
por: Savarino, Edoardo, et al.
Publicado: (2015) -
Factors of Reflux Episodes With Post-reflux Swallow-induced Peristaltic Wave in Gastroesophageal Reflux Disease
por: Xu, Hairong, et al.
Publicado: (2020) -
Schizophrenia and gastroesophageal reflux symptoms
por: Kasap, Elmas, et al.
Publicado: (2015)